BOC Sciences offers specialized exosome quality control testing services designed to ensure the safety, purity, and functionality of exosome-based products. Using state-of-the-art analytical techniques, we evaluate critical parameters such as particle size distribution, concentration, purity, and biological activity. Our expert team provides accurate and reliable results, assisting clients in the biopharmaceutical and medical research sectors to enhance the safety and efficacy of their exosome products for a variety of therapeutic applications.
Equipped with high-precision instruments like NTA, flow cytometry, TEM, and DLS to accurately measure exosome size, concentration, morphology, and surface markers.
Experienced researchers and quality control experts proficient in exosome extraction, purification, characterization, and functional validation, ensuring accurate results and expert consultations.
A well-established quality control system ensures consistent and reproducible testing processes that deliver reliable and authoritative results.
Extensive expertise in exosome research and application, allowing for quick identification and resolution of issues during testing, ensuring efficient and high-quality service.
Offering a broad range of tests for exosome properties such as size, concentration, charge, surface proteins, biological activity, and safety, catering to various client needs.
Streamlined testing procedures for increased efficiency, enabling rapid completion of complex exosome quality control tests, saving clients time and costs.
Stringent measures for data management and confidentiality to ensure the safety and privacy of client samples and results, with no unauthorized disclosure.
Constantly integrating the latest advancements in exosome research and testing methods to enhance the quality and capability of our services, providing customers with cutting-edge support.
BOC Sciences offers comprehensive quality control testing services for exosomes, supporting the full spectrum of development and application needs in research and product innovation. Leveraging advanced instrumentation and expert analytical capabilities, we ensure precise characterization of exosome quality attributes, including physicochemical properties, purity, safety, and stability, enabling clients to meet rigorous quality expectations.
We use NTA and DLS techniques to accurately measure exosome size distribution, ensuring batch-to-batch consistency and supporting downstream processing, formulation optimization, and delivery system development.
Exosome concentration is quantified via NTA and protein-based assays to ensure dosing accuracy, maintain product consistency, and support reproducibility in research, therapeutic, or diagnostic applications.
TEM and SEM imaging provide high-resolution visualization of exosome morphology, enabling assessment of shape, membrane structure, and integrity to confirm proper isolation and preservation of vesicular architecture.
We apply Western blot, ELISA, and mass spectrometry to identify and quantify key surface and internal proteins, ensuring exosome identity, functional relevance, and purity for research and product development.
qPCR and NGS platforms enable the detection and quantification of exosomal RNA/DNA cargo, supporting genetic profiling, biomarker discovery, and therapeutic evaluation across various biological and medical models.
Purity is assessed using ultracentrifugation, size-exclusion chromatography, and fluorescence labeling to identify contaminants, confirm exosome enrichment, and validate sample quality before downstream application.
Sterility testing is performed via microbial culture techniques to confirm the absence of viable bacteria or fungi in exosome preparations, ensuring biological safety and compliance with application requirements.
Using the LAL assay, we detect and quantify endotoxin contamination in exosome samples, reducing the risk of unwanted immune responses and ensuring product safety for biological use.
Thermal stability studies evaluate exosome integrity and cargo retention after exposure to temperature stress, supporting storage condition optimization and formulation robustness under varying environments.
We conduct extended stability testing under controlled storage conditions to monitor changes in exosome structure, concentration, and bioactivity, ensuring product reliability throughout its intended shelf life.
Zeta potential analysis determines the surface charge of exosomes, providing insights into colloidal stability, aggregation tendencies, and formulation behavior critical for product development and delivery efficiency.
Comprehensive LC-MS/MS-based proteomics reveals the full protein composition of exosomes, enabling functional analysis, mechanism studies, and discovery of diagnostic or therapeutic protein biomarkers.
BOC Sciences provides comprehensive exosome quality testing services tailored to various product categories, including skincare formulations, injectables, topical dressings, and over-the-counter (OTC) beauty products. Each application demands specific analytical strategies to ensure biological activity, formulation stability, and product safety. Our customized testing solutions support both R&D and manufacturing phases, helping clients ensure consistency, efficacy, and quality across a diverse product portfolio.
We perform rigorous characterization of exosome raw materials—including vesicle identity, purity, concentration, and surface markers—to ensure consistency, biological activity, and suitability for downstream formulation and therapeutic use.
Our testing includes sterility, endotoxin levels, particle size, and functional assays for injectable exosome products used in anti-aging, scar repair, and dermal regeneration, ensuring high purity and safety for transdermal applications.
We analyze hydrogel- or biomaterial-based dressings for exosome stability, sustained release behavior, and bioactivity retention, supporting their use in wound healing, skin repair, and post-treatment care.
We provide comprehensive testing for exosome-enriched beauty products, including moisturizers, serums, and lotions. Our analysis covers protein content, vesicle integrity, purity, and microbiological safety to ensure product quality and skin-enhancing performance.
BOC Sciences has developed a comprehensive, highly integrated exosome quality control testing platform dedicated to providing full-process testing and quality assessment for exosome-based products. This platform combines cutting-edge instrumentation, rigorous testing protocols, and robust data management systems to ensure that every critical aspect of exosome quality, from extraction and purification to final product evaluation, is thoroughly assessed. The platform incorporates advanced instruments designed for precise measurement and analysis of exosome properties, including particle size, concentration, morphology, surface markers, biological activity, and safety. With our extensive experience and a team of skilled professionals, BOC Sciences ensures high-throughput, high-sensitivity, and high-precision testing capabilities, making it suitable for a range of applications in biomedical, pharmaceutical, and research industries.
Exosomes have emerged as a transformative tool in aesthetic medicine, driven by their regenerative, anti-inflammatory, and signaling capabilities. Quality control testing plays a critical role in ensuring the safety, consistency, and efficacy of exosome-based aesthetic products. Below are key aesthetic applications enhanced through rigorous exosome quality assessment:
Exosomes are typically tested using methods such as nanoparticle tracking analysis (NTA) for size and concentration, Western blot or ELISA for surface markers like CD63 and CD81, and functional assays to confirm biological activity. These tests ensure that the exosomes used in aesthetic products are pure, potent, and consistent for applications like skin rejuvenation or anti-aging.
Quality control is essential in aesthetic medicine to ensure the safety, consistency, and efficacy of exosome-based treatments. Proper testing eliminates contaminants, verifies the presence of key active molecules, and confirms functional bioactivity, critical for achieving reliable outcomes in skin repair, pigmentation correction, and anti-aging therapies.
A high-quality exosome product should have a uniform particle size (30–150 nm), high purity with minimal impurities, verified surface markers such as CD63 or CD81, and demonstrated biological activity in regenerative or anti-inflammatory assays, ensuring it delivers visible and consistent aesthetic results.
Yes, potency can be verified through cell-based assays that evaluate effects on fibroblast proliferation, collagen synthesis, or skin regeneration. These tests confirm that the exosomes retain functional activity and are suitable for medical or cosmetic use in skin rejuvenation, brightening, or anti-wrinkle treatments.
Consistency is maintained by applying standardized isolation and purification methods, along with rigorous quality testing for each production batch. This includes evaluating size distribution, protein expression, and biological activity, ensuring reliable performance and reproducible results in medical or cosmetic skincare use.